Home
KTRA
KTRA News

Latest Kintara Therapeutics Inc. (KTRA) News on July 27, 2024

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

PR Newswire

19 days ago

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones

PR Newswire

a month ago

Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

ACCESSWIRE

2 months ago

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

PR Newswire

2 months ago

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA

Zacks

4 months ago

Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement

ACCESSWIRE

4 months ago

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab

PR Newswire

4 months ago

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab

Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update

PR Newswire

5 months ago

Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer

PR Newswire

5 months ago

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for December 2023

PR Newswire

6 months ago

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for December 2023

Paragon Calls Out OPT’s Inaccurate Statements About Voting on the Blue Proxy Card; Vote the Blue Proxy Card and Put an End to the Corporate Greed and Drowning Share Price

ACCESSWIRE

6 months ago

Paragon Calls Out OPT’s Inaccurate Statements About Voting on the Blue Proxy Card; Vote the Blue Proxy Card and Put an End to the Corporate Greed and Drowning Share Price

PainReform to Present at the Microcap Conference in Atlantic City

GlobeNewswire

6 months ago

PainReform to Present at the Microcap Conference in Atlantic City

7 Cyclical Penny Stocks Best Positioned for 2024

InvestorPlace

6 months ago

7 Cyclical Penny Stocks Best Positioned for 2024

Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock

Business Wire

6 months ago

Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock

SemiLEDs Reports First Quarter Fiscal Year 2024 Financial Results

Business Wire

6 months ago

SemiLEDs Reports First Quarter Fiscal Year 2024 Financial Results

Q4 Earnings Roundup: Constellation Brands (NYSE:STZ) And The Rest Of The Beverages and Alcohol Segment

StockStory

7 months ago

Q4 Earnings Roundup: Constellation Brands (NYSE:STZ) And The Rest Of The Beverages and Alcohol Segment

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

GlobeNewswire

7 months ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Sacks Parente Golf Appoints Golf Industry Veteran Jane Casanta as Newest Board Member

GlobeNewswire

7 months ago

Sacks Parente Golf Appoints Golf Industry Veteran Jane Casanta as Newest Board Member

BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD

PR Newswire

7 months ago

BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD

Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase

GlobeNewswire

7 months ago

Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase

Royalty Management Holding Corporation’s and American Resources Corporation’s Investment In Advanced Magnetic Labs, Inc. Results in Commercial Manufacturing of Permanent Magnets

ACCESSWIRE

7 months ago

Royalty Management Holding Corporation’s and American Resources Corporation’s Investment In Advanced Magnetic Labs, Inc. Results in Commercial Manufacturing of Permanent Magnets

PR Newswire

7 months ago

CLPS Incorporation Expands Overseas Credit Card Business with the Acquisition of Purple Potato Finance

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

GlobeNewswire

7 months ago

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

ACCESSWIRE

7 months ago

Ainos, Inc. Announces Stock Consolidation

Kintara Therapeutics Announces Review of Strategic Alternatives

PR Newswire

8 months ago

Kintara Therapeutics Announces Review of Strategic Alternatives

PR Newswire

8 months ago

Lixiang Education Receives Nasdaq Extension to Regain $1 Bid Price Compliance

Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement

PR Newswire

8 months ago

Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

PR Newswire

8 months ago

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries

GlobeNewswire

8 months ago

Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries

CLPS Incorporation (NASDAQ:CLPS) Will Want To Turn Around Its Return Trends

Simply Wall St.

8 months ago

CLPS Incorporation (NASDAQ:CLPS) Will Want To Turn Around Its Return Trends

ACCESSWIRE

8 months ago

Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

GlobeNewswire

8 months ago

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

PR Newswire

8 months ago

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

GlobeNewswire

8 months ago

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

ACCESSWIRE

8 months ago

Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Eastside Distilling Reports Third Quarter 2023 Financial Results

PR Newswire

8 months ago

Eastside Distilling Reports Third Quarter 2023 Financial Results

Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update

PR Newswire

8 months ago

Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update

Trio-Tech Reports First Quarter Results; Delivers First Dynamic Power Module Test System

Business Wire

8 months ago

Trio-Tech Reports First Quarter Results; Delivers First Dynamic Power Module Test System

CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan

GlobeNewswire

8 months ago

CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan

ACCESSWIRE

9 months ago

Ainos Reports Third Quarter 2023 Financial Results

Enviva Inc (EVA) Faces Headwinds as Q3 2023 Results Show Net Loss and Lower Adjusted EBITDA

GuruFocus.com

9 months ago

Enviva Inc (EVA) Faces Headwinds as Q3 2023 Results Show Net Loss and Lower Adjusted EBITDA

PR Newswire

9 months ago

Lixiang Education Announces Receipt of Nasdaq Staff Determination Letter and Intent to Request Hearing

CPS Technologies Corporation (NASDAQ:CPSH) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

CPS Technologies Corporation (NASDAQ:CPSH) Q3 2023 Earnings Call Transcript

Xilio Announces Initial Monotherapy Safety and Anti-Tumor Activity Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, in Late Line Patients with Advanced Solid Tumors

GlobeNewswire

9 months ago

Xilio Announces Initial Monotherapy Safety and Anti-Tumor Activity Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, in Late Line Patients with Advanced Solid Tumors

Inuvo to Host Third Quarter 2023 Financial Results Conference Call on Friday, November 10, at 11:00 A.M. ET

GlobeNewswire

9 months ago

Inuvo to Host Third Quarter 2023 Financial Results Conference Call on Friday, November 10, at 11:00 A.M. ET

PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023

GlobeNewswire

9 months ago

PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023

Share on Social Networks: